<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7020194\results\search\disease\results.xml">
  <result pre="especially in the lungs where it has been implicated in" exact="lung cancer," post="asthma, influenza, and idiopathic pulmonary fibrosis (IPF). CD151 interacts"/>
  <result pre="it has been implicated in lung cancer, asthma, influenza, and" exact="idiopathic pulmonary fibrosis" post="(IPF). CD151 interacts with laminin-binding integrins and growth factor"/>
  <result pre="has been implicated in lung cancer, asthma, influenza, and idiopathic" exact="pulmonary fibrosis" post="(IPF). CD151 interacts with laminin-binding integrins and growth factor"/>
  <result pre="associated with increased disease severity and poorer survival outcome in" exact="asthma" post="and lung cancer, respectively. In this review, we provide"/>
  <result pre="increased disease severity and poorer survival outcome in asthma and" exact="lung cancer," post="respectively. In this review, we provide an update on"/>
  <result pre="a therapeutic target for the treatment of lung diseases. CD151" exact="lung cancer" post="asthma influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin"/>
  <result pre="therapeutic target for the treatment of lung diseases. CD151 lung" exact="cancer" post="asthma influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin"/>
  <result pre="target for the treatment of lung diseases. CD151 lung cancer" exact="asthma" post="influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin Funding"/>
  <result pre="for the treatment of lung diseases. CD151 lung cancer asthma" exact="influenza" post="idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin Funding Ministry"/>
  <result pre="the treatment of lung diseases. CD151 lung cancer asthma influenza" exact="idiopathic pulmonary fibrosis" post="biomarker targeted therapy tetraspanin Funding Ministry of Education -"/>
  <result pre="treatment of lung diseases. CD151 lung cancer asthma influenza idiopathic" exact="pulmonary fibrosis" post="biomarker targeted therapy tetraspanin Funding Ministry of Education -"/>
  <result pre="the most common of which were asthma, lower respiratory infections," exact="chronic obstructive pulmonary disease," post="and lung cancer – and the total cost of"/>
  <result pre="were asthma, lower respiratory infections, chronic obstructive pulmonary disease, and" exact="lung cancer" post="– and the total cost of respiratory diseases in"/>
  <result pre="asthma, lower respiratory infections, chronic obstructive pulmonary disease, and lung" exact="cancer" post="– and the total cost of respiratory diseases in"/>
  <result pre="Contribution of CD151to respiratory diseases. ASM, airway smooth muscle; IPF," exact="idiopathic pulmonary fibrosis;" post="MMP7, matrix metalloproteinase-7; NSCLC, non-small cell lung cancer. CD151"/>
  <result pre="of CD151to respiratory diseases. ASM, airway smooth muscle; IPF, idiopathic" exact="pulmonary fibrosis;" post="MMP7, matrix metalloproteinase-7; NSCLC, non-small cell lung cancer. CD151"/>
  <result pre="IPF, idiopathic pulmonary fibrosis; MMP7, matrix metalloproteinase-7; NSCLC, non-small cell" exact="lung cancer." post="CD151 Cluster of Differentiation 151 was first identified as"/>
  <result pre="it protein SFA-1 as it was induced by a T-cell" exact="leukemia" post="cell line, SF-HT. The protein was subsequently reassigned as"/>
  <result pre="was reported in four of the cases as well as" exact="epidermolysis bullosa" post="and sensorineural deafness in two cases (Karamatic Crew et"/>
  <result pre="mice. The authors concluded that CD151 functions to protect against" exact="pulmonary fibrosis" post="by maintaining epithelial integrity. Besides these reports, findings from"/>
  <result pre="of its laminin-binding partners. Tumor Promoter in Lung Cancer Lung" exact="cancer" post="has a high degree of molecular heterogeneity thus giving"/>
  <result pre="characteristics leading to the distinction between small and non-small cell" exact="lung cancer" post="(NSCLC) (Herbst et al., 2008). The onslaught of molecular"/>
  <result pre="leading to the distinction between small and non-small cell lung" exact="cancer" post="(NSCLC) (Herbst et al., 2008). The onslaught of molecular"/>
  <result pre="et al., 2017; Herbst et al., 2018). The pathogenesis of" exact="lung cancer" post="and its management has been covered extensively by others"/>
  <result pre="al., 2017; Herbst et al., 2018). The pathogenesis of lung" exact="cancer" post="and its management has been covered extensively by others"/>
  <result pre="et al., 2013). Exosome protein profiling comparing a cohort of" exact="lung cancer" post="patients with non-cancer patients revealed that CD151 was one"/>
  <result pre="al., 2013). Exosome protein profiling comparing a cohort of lung" exact="cancer" post="patients with non-cancer patients revealed that CD151 was one"/>
  <result pre="was one of the markers found to be upregulated in" exact="lung cancer" post="(Sandfeld-Paulsen et al., 2016). This study showed that whilst"/>
  <result pre="one of the markers found to be upregulated in lung" exact="cancer" post="(Sandfeld-Paulsen et al., 2016). This study showed that whilst"/>
  <result pre="exosomes in circulation to act as components for crosstalk between" exact="cancer" post="initiating cells and their environment (Yue et al., 2015)."/>
  <result pre="(Yue et al., 2015). This highlights their key role in" exact="cancer" post="and as a mediator of cell-cell communication. Use of"/>
  <result pre="been employed to explore the functional significance of CD151. In" exact="lung cancer" post="cells, CD151 knockdown resulted in impairment of several cancer-promoting"/>
  <result pre="employed to explore the functional significance of CD151. In lung" exact="cancer" post="cells, CD151 knockdown resulted in impairment of several cancer-promoting"/>
  <result pre="and airway inflammation (Barnes, 1996; Kudo et al., 2013). Current" exact="asthma" post="treatment is mainly focused on long-term clinical control of"/>
  <result pre="asthma treatment is mainly focused on long-term clinical control of" exact="asthma" post="and rapid-acting symptom relief. However, these drugs are suboptimal"/>
  <result pre="therapeutic targeting of these mechanisms may contribute greatly to improved" exact="asthma" post="management. Expression of CD51 is clinically relevant to asthma"/>
  <result pre="improved asthma management. Expression of CD51 is clinically relevant to" exact="asthma" post="as immunohistochemical analysis of human bronchial biopsy specimens for"/>
  <result pre="airway smooth muscle bundles were highest in mild or moderate" exact="asthma" post="subjects compared with non-asthmatic subjects (Qiao et al., 2017)."/>
  <result pre="determined is whether high CD151 expression is a result of" exact="asthma" post="or whether elevated expression of CD151 results in asthma."/>
  <result pre="in Influenza Viral Export An estimated 5% of adults develop" exact="influenza" post="symptoms annually with severe cases leading to conditions such"/>
  <result pre="bronchitis and pneumonia. These seasonal epidemics are largely due to" exact="influenza" post="viruses A and B. Influenza viruses are segmented, negative-sense"/>
  <result pre="Hochdorfer et al., 2016). CD151 plays a critical role in" exact="influenza" post="A virus signaling (IAV) (Qiao et al., 2018). The"/>
  <result pre="CD151 to be developed as a novel therapy to treat" exact="influenza" post="and other viral infections. Targeting CD151 is especially beneficial"/>
  <result pre="season. Protective or Progressive Role in Idiopathic Pulmonary Fibrosis Idiopathic" exact="pulmonary fibrosis" post="(IPF) is a form of interstitial pneumonia that features"/>
  <result pre="Fibrosis Idiopathic pulmonary fibrosis (IPF) is a form of interstitial" exact="pneumonia" post="that features the chronic and progressive scarring of the"/>
  <result pre="2017; Mora et al., 2017). Interestingly, CD151-null mice spontaneously developed" exact="pulmonary fibrosis" post="features observed at 30 weeks and exhibited accelerated bleomycin-induced"/>
  <result pre="30 weeks and exhibited accelerated bleomycin-induced lung injury in the" exact="pulmonary fibrosis" post="model, suggesting a protective role of CD151 in IPF."/>
  <result pre="gefitinib upregulated CD151 protein levels in MDA-MB-231 breast and A549" exact="lung carcinoma" post="cell lines, respectively. In this study, the group showed"/>
  <result pre="whether the same hypoxic conditions can reduce CD151 in a" exact="lung cancer" post="setting. Mechanisms Underlying CD151 Regulation Whilst CD151 expression modulation"/>
  <result pre="the same hypoxic conditions can reduce CD151 in a lung" exact="cancer" post="setting. Mechanisms Underlying CD151 Regulation Whilst CD151 expression modulation"/>
  <result pre="role in determining disease progression, whether in promoting pathophysiology of" exact="lung cancer," post="asthma, and influenza or in potentially protecting against IPF,"/>
  <result pre="progression, whether in promoting pathophysiology of lung cancer, asthma, and" exact="influenza" post="or in potentially protecting against IPF, there is a"/>
  <result pre="The prognostic value of CD151 was previously emphasized in low-grade" exact="prostate cancer," post="in which CD151 expression could predict the clinical outcome"/>
  <result pre="et al., 2004). Given the strong association between CD151 and" exact="lung cancer" post="(Tokuhara et al., 2001; Kwon et al., 2013), especially"/>
  <result pre="al., 2004). Given the strong association between CD151 and lung" exact="cancer" post="(Tokuhara et al., 2001; Kwon et al., 2013), especially"/>
  <result pre="explored where a high level of accuracy (72%) in detecting" exact="cancer" post="in adenocarcinoma patients was observed (Sandfeld-Paulsen et al., 2016)."/>
  <result pre="of CD151 in a milieu of processes that contribute to" exact="lung disease" post="pathophysiology, targeting CD151 in a clinical setting is justifiable."/>
  <result pre="antibodies has been shown to impair cellular processes at multiple" exact="cancer" post="stages. Tumor growth potential, neoangiogenesis and metastasis following injection"/>
  <result pre="Tumor growth potential, neoangiogenesis and metastasis following injection with a" exact="hepatocellular carcinoma" post="cell line was also inhibited in mice that were"/>
  <result pre="shown to impair pulmonary metastasis in mice injected with either" exact="colon cancer" post="or fibrosarcoma cell lines (Kohno et al., 2002). Whether"/>
  <result pre="to impair pulmonary metastasis in mice injected with either colon" exact="cancer" post="or fibrosarcoma cell lines (Kohno et al., 2002). Whether"/>
  <result pre="pulmonary metastasis in mice injected with either colon cancer or" exact="fibrosarcoma" post="cell lines (Kohno et al., 2002). Whether or not"/>
  <result pre="be explored, although its anti-cancer properties for the treatment of" exact="lung cancer" post="are promising. Besides the use of monoclonal antibodies, CD151"/>
  <result pre="explored, although its anti-cancer properties for the treatment of lung" exact="cancer" post="are promising. Besides the use of monoclonal antibodies, CD151"/>
  <result pre="airway hyperresponsive processes decreased significantly in allergen-induced CD151-null mice. Following" exact="influenza" post="A virus infection, CD151-null mice exhibited better survival and"/>
  <result pre="developmental conditions. The impact of CD151 was also reported in" exact="breast cancer" post="in which mammary tumor initiation, tumor growth, survival, and"/>
  <result pre="conditions. The impact of CD151 was also reported in breast" exact="cancer" post="in which mammary tumor initiation, tumor growth, survival, and"/>
  <result pre="been implicated in several diseases, including respiratory diseases such as" exact="lung cancer," post="asthma, influenza and IPF (Figure 1). The majority of"/>
  <result pre="several diseases, including respiratory diseases such as lung cancer, asthma," exact="influenza" post="and IPF (Figure 1). The majority of studies link"/>
  <result pre="or as a prognostic biomarker given its relevance in predicting" exact="lung cancer" post="or asthma severity. Furthermore, CD151 monoclonal antibodies, gene deletion,"/>
  <result pre="as a prognostic biomarker given its relevance in predicting lung" exact="cancer" post="or asthma severity. Furthermore, CD151 monoclonal antibodies, gene deletion,"/>
  <result pre="prognostic biomarker given its relevance in predicting lung cancer or" exact="asthma" post="severity. Furthermore, CD151 monoclonal antibodies, gene deletion, and nanotechnology"/>
  <result pre="CD151 protein expression predicts the clinical outcome of low-grade primary" exact="prostate cancer" post="better than histologic grading: a new prognostic indicator?Cancer Epidemiol."/>
  <result pre="protein expression predicts the clinical outcome of low-grade primary prostate" exact="cancer" post="better than histologic grading: a new prognostic indicator?Cancer Epidemiol."/>
  <result pre="D.HurdS. S.BarnesP. J.BousquetJ.DrazenJ. M.FitzgeraldJ. M.et al. (2008). Global strategy for" exact="asthma" post="management and prevention: GINA executive summary.Eur. Respir. J.31143–178. 10.1183/09031936.0013870718166595"/>
  <result pre="ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of" exact="prostate cancer" post="in the TRAMP model.Mol. Cancer Res.1195–105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA."/>
  <result pre="of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate" exact="cancer" post="in the TRAMP model.Mol. Cancer Res.1195–105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA."/>
  <result pre="De GalarretaM.et al. (2018). Cell type-specific pharmacological kinase inhibition for" exact="cancer" post="chemoprevention.Nanomedicine14317–325. 10.1016/j.nano.2017.11.00429157977 FerkolT.SchraufnagelD. (2014). The global burden of respiratory"/>
  <result pre="mood stabilizing drugs?Neuropsychopharmacology25729–736. 10.1016/s0893-133x(01)00269-x11682256 HwangS.TakimotoT.HemlerM. E. (2019). Integrin-independent support of" exact="cancer" post="drug resistance by tetraspanin CD151.Cell. Mol. Life Sci.761595–1604. 10.1007/s00018-019-03014-730778617"/>
  <result pre="(2005). CD151 forms a functional complex with c-Met in human" exact="salivary gland cancer" post="cells.Biochem. Biophys. Res. Commun.336408–416. 10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances"/>
  <result pre="forms a functional complex with c-Met in human salivary gland" exact="cancer" post="cells.Biochem. Biophys. Res. Commun.336408–416. 10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances"/>
  <result pre="10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances cell motility and metastasis of" exact="cancer" post="cells in the presence of focal adhesion kinase.Int. J."/>
  <result pre="10.1038/nrdp.2017.7429052582 MatsumuraY.MaedaH. (1986). A new concept for macromolecular therapeutics in" exact="cancer" post="chemotherapy: mechanism of tumoritropic accumulation of proteins and the"/>
  <result pre="extracellular vesicles.Front. Immunol.5:658. 10.3389/fimmu.2014.0065825566267 MoraA. L.RojasM.PardoA.SelmanM. (2017). Emerging therapies for" exact="idiopathic pulmonary fibrosis," post="a progressive age-related disease.Nat. Rev. Drug Discov.16755–772. 10.1038/nrd.2017.17028983101 MukherjeeA.PaulM.MukherjeeS."/>
  <result pre="vesicles.Front. Immunol.5:658. 10.3389/fimmu.2014.0065825566267 MoraA. L.RojasM.PardoA.SelmanM. (2017). Emerging therapies for idiopathic" exact="pulmonary fibrosis," post="a progressive age-related disease.Nat. Rev. Drug Discov.16755–772. 10.1038/nrd.2017.17028983101 MukherjeeA.PaulM.MukherjeeS."/>
  <result pre="CD151, a novel host factor of nuclear export signaling in" exact="influenza" post="virus infection.J. Allergy Clin. Immunol.1411799–1817. 10.1016/j.jaci.2017.11.03229274410 ReckM.HeigenerD. F.MokT.SoriaJ. C.RabeK."/>
  <result pre="A summary of the new GINA strategy: a roadmap to" exact="asthma" post="control.Eur. Respir. J.46622–639. 10.1183/13993003.00853-201526206872 RicheldiL.CollardH. R.JonesM. G. (2017). Idiopathic"/>
  <result pre="RosenblumD.JoshiN.TaoW.KarpJ. M.PeerD. (2018). Progress and challenges towards targeted delivery of" exact="cancer" post="therapeutics.Nat. Commun.9:1410. 10.1038/s41467-018-03705-y29650952 SachsN.KreftM.Van Den Bergh WeermanM. A.BeynonA. J.PetersT."/>
  <result pre="metastasis.Cancer Res.593812–3820. 10447000 ThaliM. (2011). Tetraspanin functions during HIV-1 and" exact="influenza" post="virus replication.Biochem. Soc. Trans.39529–531. 10.1042/BST039052921428933 TokuharaT.HasegawaH.HattoriN.IshidaH.TakiT.TachibanaS.et al. (2001). Clinical"/>
  <result pre="Cancer Res.74109–4114. 11751509 TsujinoK.TakedaY.AraiT.ShintaniY.InagakiR.SaigaH.et al. (2012). Tetraspanin CD151 protects against" exact="pulmonary fibrosis" post="by maintaining epithelial integrity.Am. J. Respir. Crit. Care Med.186170–180."/>
  <result pre="al. (2018). Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like" exact="epidermolysis bullosa" post="with multi-systemic manifestations including nephropathy.Matrix Biol.6622–33. 10.1016/j.matbio.2017.11.00329138120 van SprielA."/>
  <result pre="B.ZhouK.KosP.et al. (2016). Functional polyesters enable selective siRNA delivery to" exact="lung cancer" post="over matched normal cells.Proc. Natl. Acad. Sci. U.S.A.113E5702–E5710. 10.1073/pnas.160688611327621434"/>
  <result pre="al. (2016). Functional polyesters enable selective siRNA delivery to lung" exact="cancer" post="over matched normal cells.Proc. Natl. Acad. Sci. U.S.A.113E5702–E5710. 10.1073/pnas.160688611327621434"/>
  <result pre="E.et al. (2010). Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes" exact="breast cancer" post="cells to ErbB2 antagonists.Cancer Res.702256–2263. 10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM."/>
  <result pre="al. (2010). Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast" exact="cancer" post="cells to ErbB2 antagonists.Cancer Res.702256–2263. 10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM."/>
  <result pre="10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM. I.ZhouP.SharmaC.KazarovA. R.et al. (2008). CD151 accelerates" exact="breast cancer" post="by regulating α(6) integrin function, signaling, and molecular organization.Cancer"/>
  <result pre="YangX. H.RichardsonA. L.Torres-ArzayusM. I.ZhouP.SharmaC.KazarovA. R.et al. (2008). CD151 accelerates breast" exact="cancer" post="by regulating α(6) integrin function, signaling, and molecular organization.Cancer"/>
  <result pre="and Tspan8 are essential exosome components for the crosstalk between" exact="cancer" post="initiating cells and their surrounding.Oncotarget62366–2384. 25544774 ZevianS.WinterwoodN. E.StippC. S."/>
 </snippets>
</snippetsTree>
